Biomarin Pharmaceutical (BMRN) Non-cash Items (2010 - 2018)

Biomarin Pharmaceutical has disclosed Non-cash Items across 9 years of filings, most recently posting $5.9 million for Q4 2018.

• Quarterly Non-cash Items fell 97.89% year-over-year to $5.9 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $5.9 million (down 97.89% YoY) and the FY2018 annual result came in at $5.9 million, down 10.88% from the prior year.
• Non-cash Items fell to $5.9 million in Q4 2018, from $281.1 million in the prior quarter.
• Over five years, Non-cash Items peaked at $630.9 million in Q4 2015 and troughed at $5.9 million in Q4 2018.
• A 5-year average of $364.5 million and a median of $304.4 million in 2016 frame the typical range for Non-cash Items.
• Annual changes were most pronounced in 2014 — Non-cash Items advanced 25.65% — and 2018, when it slumped 97.89%.
• Tracing BMRN's Non-cash Items over 5 years: stood at $600.1 million in 2014, then increased by 5.14% to $630.9 million in 2015, then plunged by 51.76% to $304.4 million in 2016, then slipped by 7.63% to $281.1 million in 2017, then sank by 97.89% to $5.9 million in 2018.
• Business Quant data shows BMRN's Non-cash Items at $5.9 million in Q4 2018, $281.1 million in Q4 2017, and $304.4 million in Q4 2016.